195 related articles for article (PubMed ID: 25220716)
1. Prognostic value and reproducibility of pretreatment CT texture features in stage III non-small cell lung cancer.
Fried DV; Tucker SL; Zhou S; Liao Z; Mawlawi O; Ibbott G; Court LE
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):834-42. PubMed ID: 25220716
[TBL] [Abstract][Full Text] [Related]
2. Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features.
Khorrami M; Jain P; Bera K; Alilou M; Thawani R; Patil P; Ahmad U; Murthy S; Stephans K; Fu P; Velcheti V; Madabhushi A
Lung Cancer; 2019 Sep; 135():1-9. PubMed ID: 31446979
[TBL] [Abstract][Full Text] [Related]
3. Preoperative CT-based radiomic prognostic index to predict the benefit of postoperative radiotherapy in patients with non-small cell lung cancer: a multicenter study.
Ma Z; Men Y; Liu Y; Bao Y; Liu Q; Yang X; Wang J; Deng L; Zhai Y; Bi N; Wang L; Hui Z
Cancer Imaging; 2024 May; 24(1):61. PubMed ID: 38741207
[TBL] [Abstract][Full Text] [Related]
4. Classification of Histological Types and Stages in Non-small Cell Lung Cancer Using Radiomic Features Based on CT Images.
Lin J; Yu Y; Zhang X; Wang Z; Li S
J Digit Imaging; 2023 Jun; 36(3):1029-1037. PubMed ID: 36828962
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapy.
Richlitzki C; Wiesweg M; Metzenmacher M; Guberina N; Pöttgen C; Hautzel H; Eberhardt WEE; Darwiche K; Theegarten D; Aigner C; Bölükbas S; Schuler M; Stuschke M; Guberina M
Sci Rep; 2024 Jun; 14(1):13765. PubMed ID: 38877146
[TBL] [Abstract][Full Text] [Related]
6. CT texture features of liver parenchyma for predicting development of metastatic disease and overall survival in patients with colorectal cancer.
Lee SJ; Zea R; Kim DH; Lubner MG; Deming DA; Pickhardt PJ
Eur Radiol; 2018 Apr; 28(4):1520-1528. PubMed ID: 29164382
[TBL] [Abstract][Full Text] [Related]
7. Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non-Small Cell Lung Cancer.
Khorrami M; Prasanna P; Gupta A; Patil P; Velu PD; Thawani R; Corredor G; Alilou M; Bera K; Fu P; Feldman M; Velcheti V; Madabhushi A
Cancer Immunol Res; 2020 Jan; 8(1):108-119. PubMed ID: 31719058
[TBL] [Abstract][Full Text] [Related]
8. Radiomics-based Prognosis Analysis for Non-Small Cell Lung Cancer.
Zhang Y; Oikonomou A; Wong A; Haider MA; Khalvati F
Sci Rep; 2017 Apr; 7():46349. PubMed ID: 28418006
[TBL] [Abstract][Full Text] [Related]
9. CYFRA 21-1, CA 125 and CEA provide additional prognostic value in NSCLC patients with stable disease at first CT scan.
Muley T; Schneider MA; Meister M; Thomas M; Heußel CP; Kriegsmann M; Holdenrieder S; Wehnl B; Rolny V; Mang A; Gerber R; Herth F
Tumour Biol; 2024; 46(s1):S163-S175. PubMed ID: 37840516
[TBL] [Abstract][Full Text] [Related]
10. Revisiting the relationship between tumour volume and diameter in advanced NSCLC patients: An exercise to maximize the utility of each measure to assess response to therapy.
Nishino M; Jackman DM; DiPiro PJ; Hatabu H; Jänne PA; Johnson BE
Clin Radiol; 2014 Aug; 69(8):841-8. PubMed ID: 24857677
[TBL] [Abstract][Full Text] [Related]
11. Rank acquisition impact on radiomics estimation (AсquIRE) in chest CT imaging: A retrospective multi-site, multi-use-case study.
Cherezov D; Viswanathan VS; Fu P; Gupta A; Madabhushi A
Comput Methods Programs Biomed; 2024 Feb; 244():107990. PubMed ID: 38194767
[TBL] [Abstract][Full Text] [Related]
12. The influence of gender, race, and marital status on survival in lung cancer patients: analysis of Radiation Therapy Oncology Group trials.
Siddiqui F; Bae K; Langer CJ; Coyne JC; Gamerman V; Komaki R; Choy H; Curran WJ; Watkins-Bruner D; Movsas B
J Thorac Oncol; 2010 May; 5(5):631-9. PubMed ID: 20432520
[TBL] [Abstract][Full Text] [Related]
13. Computed Tomography-based Prognostication in Lung Adenocarcinomas through Histopathological Feature Learning: A Retrospective Multicenter Study.
Lee KH; Lee JH; Park S; Jeon YK; Chung DH; Kim YT; Goo JM; Kim H
Ann Am Thorac Soc; 2023 Jul; 20(7):1020-1028. PubMed ID: 37075305
[No Abstract] [Full Text] [Related]
14. Reproducibility of four-dimensional computed tomography-based lung ventilation imaging.
Yamamoto T; Kabus S; von Berg J; Lorenz C; Chung MP; Hong JC; Loo BW; Keall PJ
Acad Radiol; 2012 Dec; 19(12):1554-65. PubMed ID: 22975070
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the Diagnosis Model of Peripheral Non-Small-Cell Lung Cancer under Computed Tomography Images.
Xie Z; Zhang H
J Healthc Eng; 2022; 2022():3107965. PubMed ID: 35222880
[TBL] [Abstract][Full Text] [Related]
16. Identification of CT radiomic features robust to acquisition and segmentation variations for improved prediction of radiotherapy-treated lung cancer patient recurrence.
Louis T; Lucia F; Cousin F; Mievis C; Jansen N; Duysinx B; Le Pennec R; Visvikis D; Nebbache M; Rehn M; Hamya M; Geier M; Salaun PY; Schick U; Hatt M; Coucke P; Lovinfosse P; Hustinx R
Sci Rep; 2024 Apr; 14(1):9028. PubMed ID: 38641673
[TBL] [Abstract][Full Text] [Related]
17. Associations between radiologist-defined semantic and automatically computed radiomic features in non-small cell lung cancer.
Yip SSF; Liu Y; Parmar C; Li Q; Liu S; Qu F; Ye Z; Gillies RJ; Aerts HJWL
Sci Rep; 2017 Jun; 7(1):3519. PubMed ID: 28615677
[TBL] [Abstract][Full Text] [Related]
18. Deep pathomics: A new image-based tool for predicting response to treatment in stage III non-small cell lung cancer.
Nibid L; Greco C; Cordelli E; Sabarese G; Fiore M; Liu CZ; Ippolito E; Sicilia R; Miele M; Tortora M; Taffon C; Rakaee M; Soda P; Ramella S; Perrone G
PLoS One; 2023; 18(11):e0294259. PubMed ID: 38015944
[TBL] [Abstract][Full Text] [Related]
19. Novel Radiomic Measurements of Tumor-Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple Cancers.
Braman N; Prasanna P; Bera K; Alilou M; Khorrami M; Leo P; Etesami M; Vulchi M; Turk P; Gupta A; Jain P; Fu P; Pennell N; Velcheti V; Abraham J; Plecha D; Madabhushi A
Clin Cancer Res; 2022 Oct; 28(20):4410-4424. PubMed ID: 35727603
[TBL] [Abstract][Full Text] [Related]
20. The predictive value of the change of the number of pixels under different CT value intervals in the CT-occult central lung squamous cell carcinoma and squamous epithelial precancerous lesions.
Zhou J; Yu B; Guo P; Wang S
BMC Pulm Med; 2023 Nov; 23(1):426. PubMed ID: 37924039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
